Laboratory Medicine ›› 2021, Vol. 36 ›› Issue (12): 1258-1263.DOI: 10.3969/j.issn.1673-8640.2021.012.013
Previous Articles Next Articles
ZHENG Xin, HUANG Qi, XING Shan, TAN Xiaoli, DAI Shuqin, LIU Wanli, LIU Xiaomin()
Received:
2020-10-08
Online:
2021-12-30
Published:
2021-12-29
Contact:
LIU Xiaomin
CLC Number:
ZHENG Xin, HUANG Qi, XING Shan, TAN Xiaoli, DAI Shuqin, LIU Wanli, LIU Xiaomin. Evaluation of 2 blood cultures' performance with different antibiotic adsorption materials in detecting pathogens on BacT/ALERT system[J]. Laboratory Medicine, 2021, 36(12): 1258-1263.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2021.012.013
大类 | 种类 | 菌株 |
---|---|---|
革兰阳性球菌 | 葡萄球菌 | 金黄色葡萄球菌(ATCC 29213) |
革兰阳性球菌 | 葡萄球菌 | 溶血葡萄球菌(临床菌株) |
革兰阳性球菌 | 链球菌 | 肺炎链球菌(ATCC 49619) |
革兰阳性杆菌 | 棒状厌氧菌 | 产气荚膜梭菌(临床菌株) |
革兰阴性杆菌 | 肠杆菌科 | 大肠埃希菌(ATCC 25922) |
革兰阴性杆菌 | 肠杆菌科 | 肺炎克雷伯菌(临床菌株) |
革兰阴性杆菌 | 肠杆菌科 | 阴沟肠杆菌(临床菌株) |
革兰阴性杆菌 | 非发酵菌 | 铜绿假单胞菌(ATCC 27853) |
革兰阴性杆菌 | 非发酵菌 | 鲍曼不动杆菌(临床菌株) |
革兰阴性杆菌 | 非发酵菌 | 嗜麦芽单胞菌(临床菌株) |
革兰阴性杆菌 | 苛养菌 | 流感嗜血杆菌(临床菌株) |
革兰阴性球菌 | 苛养菌 | 脑膜炎奈瑟菌(临床菌株) |
真菌 | 念珠菌属 | 光滑念珠菌(临床菌株) |
真菌 | 念珠菌属 | 近平滑念珠菌(ATCC 22019) |
真菌 | 念珠菌属 | 热带念珠菌(临床菌株) |
真菌 | 念珠菌属 | 克柔念珠菌(ATCC 6258) |
真菌 | 念珠菌属 | 白念珠菌(ATCC 14053) |
真菌 | 念珠菌属 | 白念珠菌(临床菌株) |
大类 | 种类 | 菌株 |
---|---|---|
革兰阳性球菌 | 葡萄球菌 | 金黄色葡萄球菌(ATCC 29213) |
革兰阳性球菌 | 葡萄球菌 | 溶血葡萄球菌(临床菌株) |
革兰阳性球菌 | 链球菌 | 肺炎链球菌(ATCC 49619) |
革兰阳性杆菌 | 棒状厌氧菌 | 产气荚膜梭菌(临床菌株) |
革兰阴性杆菌 | 肠杆菌科 | 大肠埃希菌(ATCC 25922) |
革兰阴性杆菌 | 肠杆菌科 | 肺炎克雷伯菌(临床菌株) |
革兰阴性杆菌 | 肠杆菌科 | 阴沟肠杆菌(临床菌株) |
革兰阴性杆菌 | 非发酵菌 | 铜绿假单胞菌(ATCC 27853) |
革兰阴性杆菌 | 非发酵菌 | 鲍曼不动杆菌(临床菌株) |
革兰阴性杆菌 | 非发酵菌 | 嗜麦芽单胞菌(临床菌株) |
革兰阴性杆菌 | 苛养菌 | 流感嗜血杆菌(临床菌株) |
革兰阴性球菌 | 苛养菌 | 脑膜炎奈瑟菌(临床菌株) |
真菌 | 念珠菌属 | 光滑念珠菌(临床菌株) |
真菌 | 念珠菌属 | 近平滑念珠菌(ATCC 22019) |
真菌 | 念珠菌属 | 热带念珠菌(临床菌株) |
真菌 | 念珠菌属 | 克柔念珠菌(ATCC 6258) |
真菌 | 念珠菌属 | 白念珠菌(ATCC 14053) |
真菌 | 念珠菌属 | 白念珠菌(临床菌株) |
抗菌药物 | 最大血药浓度[ | 血培养瓶类型 | 接种菌株 |
---|---|---|---|
万古霉素 | 50 | 需氧+厌氧(FAN plus+FAN) | 金黄色葡萄球菌(ATCC 29213) |
达托霉素 | 99 | 需氧+厌氧(FAN plus+FAN) | 金黄色葡萄球菌(ATCC 29213) |
哌拉西林-他唑巴坦 | 242-24 | 需氧(FA plus/FA) | 铜绿假单胞菌(ATCC 27853) |
亚胺培南 | 40 | 厌氧(FN plus/FN) | 大肠埃希菌(ATCC 25922) |
抗菌药物 | 最大血药浓度[ | 血培养瓶类型 | 接种菌株 |
---|---|---|---|
万古霉素 | 50 | 需氧+厌氧(FAN plus+FAN) | 金黄色葡萄球菌(ATCC 29213) |
达托霉素 | 99 | 需氧+厌氧(FAN plus+FAN) | 金黄色葡萄球菌(ATCC 29213) |
哌拉西林-他唑巴坦 | 242-24 | 需氧(FA plus/FA) | 铜绿假单胞菌(ATCC 27853) |
亚胺培南 | 40 | 厌氧(FN plus/FN) | 大肠埃希菌(ATCC 25922) |
细菌及其大类 | 细菌种属 | 需氧血培养瓶 | 厌氧血培养瓶 | |||||
---|---|---|---|---|---|---|---|---|
FA plus | FA | P值 | FN plus | FN | P值 | |||
革兰阳性菌 | ||||||||
金黄色葡萄球菌 | 葡萄球菌属 | 11.68±0.21 | 13.28±0.08 | 0.01 | 10.52±0.00 | 14.32±0.32 | 0.01 | |
溶血葡萄球菌 | 葡萄球菌属 | 13.68±0.00 | 14.88±0.00 | 0.52 | 34.56±3.04 | |||
肺炎链球菌 | 链球菌属 | 14.24±0.42 | 16.96±0.29 | 0.01 | 21.20±1.04 | 35.68±2.54 | 0.02 | |
产气荚膜梭菌 | 梭菌属菌 | 10.80±0.17 | 9.44±0.10 | 0.003 | ||||
革兰阴性菌 | ||||||||
大肠埃希菌 | 肠杆菌科 | 10.32±0.00 | 11.44±0.08 | 0.06 | 9.92±0.08 | 9.84±0.08 | 0.08 | |
肺炎克雷伯菌 | 肠杆菌科 | 10.16±0.16 | 10.88±0.08 | 0.02 | 10.32±0.00 | 10.96±0.08 | 0.02 | |
阴沟肠杆菌 | 肠杆菌科 | 11.28±0.14 | 12.64±0.08 | 0.003 | 10.88±0.08 | 11.36±0.16 | 0.06 | |
流感嗜血杆菌 | 嗜血杆菌属 | 14.40±0.00 | 82.64±2.36 | 0.001 | ||||
脑膜炎奈瑟菌 | 奈瑟氏菌属 | 14.56±0.08 | 16.64±0.29 | 0.01 | ||||
铜绿假单胞菌 | 非发酵菌 | 16.08±0.14 | 18.00±0.14 | 0.001 | ||||
鲍曼不动杆菌 | 非发酵菌 | 11.76±0.14 | 13.04±0.08 | 0.003 | ||||
嗜麦芽单胞菌 | 非发酵菌 | 23.12±0.32 | 23.04±0.55 | 0.91 | ||||
真菌(酵母菌) | ||||||||
光滑念珠菌 | 念珠菌属 | 23.68±0.29 | 42.64±0.58 | 0 | ||||
近平滑念珠菌 | 念珠菌属 | 41.92±0.08 | 48.00±0.28 | 0.01 | ||||
热带念珠菌 | 念珠菌属 | 15.20±0.29 | 16.88±0.16 | 0.01 | ||||
克柔念珠菌 | 念珠菌属 | 20.72±0.16 | 28.56±0.28 | 0 | ||||
白念珠菌(临床菌株) | 念珠菌属 | 26.56±0.21 | 22.96±0.16 | 0.001 | ||||
白念珠菌(ATCC 14053) | 念珠菌属 | 30.00±0.42 | 22.56±0.14 | 0.01 |
细菌及其大类 | 细菌种属 | 需氧血培养瓶 | 厌氧血培养瓶 | |||||
---|---|---|---|---|---|---|---|---|
FA plus | FA | P值 | FN plus | FN | P值 | |||
革兰阳性菌 | ||||||||
金黄色葡萄球菌 | 葡萄球菌属 | 11.68±0.21 | 13.28±0.08 | 0.01 | 10.52±0.00 | 14.32±0.32 | 0.01 | |
溶血葡萄球菌 | 葡萄球菌属 | 13.68±0.00 | 14.88±0.00 | 0.52 | 34.56±3.04 | |||
肺炎链球菌 | 链球菌属 | 14.24±0.42 | 16.96±0.29 | 0.01 | 21.20±1.04 | 35.68±2.54 | 0.02 | |
产气荚膜梭菌 | 梭菌属菌 | 10.80±0.17 | 9.44±0.10 | 0.003 | ||||
革兰阴性菌 | ||||||||
大肠埃希菌 | 肠杆菌科 | 10.32±0.00 | 11.44±0.08 | 0.06 | 9.92±0.08 | 9.84±0.08 | 0.08 | |
肺炎克雷伯菌 | 肠杆菌科 | 10.16±0.16 | 10.88±0.08 | 0.02 | 10.32±0.00 | 10.96±0.08 | 0.02 | |
阴沟肠杆菌 | 肠杆菌科 | 11.28±0.14 | 12.64±0.08 | 0.003 | 10.88±0.08 | 11.36±0.16 | 0.06 | |
流感嗜血杆菌 | 嗜血杆菌属 | 14.40±0.00 | 82.64±2.36 | 0.001 | ||||
脑膜炎奈瑟菌 | 奈瑟氏菌属 | 14.56±0.08 | 16.64±0.29 | 0.01 | ||||
铜绿假单胞菌 | 非发酵菌 | 16.08±0.14 | 18.00±0.14 | 0.001 | ||||
鲍曼不动杆菌 | 非发酵菌 | 11.76±0.14 | 13.04±0.08 | 0.003 | ||||
嗜麦芽单胞菌 | 非发酵菌 | 23.12±0.32 | 23.04±0.55 | 0.91 | ||||
真菌(酵母菌) | ||||||||
光滑念珠菌 | 念珠菌属 | 23.68±0.29 | 42.64±0.58 | 0 | ||||
近平滑念珠菌 | 念珠菌属 | 41.92±0.08 | 48.00±0.28 | 0.01 | ||||
热带念珠菌 | 念珠菌属 | 15.20±0.29 | 16.88±0.16 | 0.01 | ||||
克柔念珠菌 | 念珠菌属 | 20.72±0.16 | 28.56±0.28 | 0 | ||||
白念珠菌(临床菌株) | 念珠菌属 | 26.56±0.21 | 22.96±0.16 | 0.001 | ||||
白念珠菌(ATCC 14053) | 念珠菌属 | 30.00±0.42 | 22.56±0.14 | 0.01 |
抗菌药物 | 细菌名称 | 实验组需氧瓶 | 实验组厌氧瓶 | 菌株有效性对照(需氧瓶) | 菌株有效性对照(厌氧瓶) | 抗菌药物有效性对照 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FA Plus | FA | FN Plus | FN | FA Plus | FA | FN Plus | FN | FN Plus | FN | ||||||
万古霉素 | 金黄色葡萄球菌 | 18.08±1.06 | 未生长 | 28.16±4.79 | 未生长 | 11.52 | 13.08 | 11.28 | 14.64 | 未生长 | 未生长 | ||||
达托霉素 | 金黄色葡萄球菌 | 12.72±0.14 | 13.20±0.24 | 11.76±0.24* | 15.28+0.35 | 11.28 | 12.72 | 11.76 | 14.4 | 未生长 | 未生长 | ||||
哌拉西林-他唑巴坦 | 铜绿假单胞菌 | 14.48±0.08 | 未生长 | 14.64 | 15.96 | 未生长 | |||||||||
亚胺培南 | 大肠埃希菌 | 12.48±0.60 | 未生长 | 10.32 | 10.32 | 未生长 | |||||||||
复苏率/% | 100 | 33 | 100 | 33 |
抗菌药物 | 细菌名称 | 实验组需氧瓶 | 实验组厌氧瓶 | 菌株有效性对照(需氧瓶) | 菌株有效性对照(厌氧瓶) | 抗菌药物有效性对照 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FA Plus | FA | FN Plus | FN | FA Plus | FA | FN Plus | FN | FN Plus | FN | ||||||
万古霉素 | 金黄色葡萄球菌 | 18.08±1.06 | 未生长 | 28.16±4.79 | 未生长 | 11.52 | 13.08 | 11.28 | 14.64 | 未生长 | 未生长 | ||||
达托霉素 | 金黄色葡萄球菌 | 12.72±0.14 | 13.20±0.24 | 11.76±0.24* | 15.28+0.35 | 11.28 | 12.72 | 11.76 | 14.4 | 未生长 | 未生长 | ||||
哌拉西林-他唑巴坦 | 铜绿假单胞菌 | 14.48±0.08 | 未生长 | 14.64 | 15.96 | 未生长 | |||||||||
亚胺培南 | 大肠埃希菌 | 12.48±0.60 | 未生长 | 10.32 | 10.32 | 未生长 | |||||||||
复苏率/% | 100 | 33 | 100 | 33 |
[1] |
ADHIKARI N K, FOWLER R A, BHAGWANJEE S, et al. Critical care and the global burden of critical illness in adults[J]. Lancet, 2010, 376(9749):1339-1346.
DOI URL |
[2] |
KUMAR A, ELLIS P, ARABI Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock[J]. Chest, 2009, 136(5):1237-1248.
DOI URL |
[3] |
KUMAR A, ROBERTS D, WOOD K E, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Crit Care Med, 2006, 34(6):1589-1596.
DOI URL |
[4] | 国家卫生计生委办公厅. 关于进一步加强抗菌药物临床应用管理遏制细菌耐药的通知:国卫办医发[2017]10号[EB/OL]. (2017-03-03)[2020-01-01]. http://www.nhc.gov.cn/yzygj/s7659/201703/d2f580480cef4ab1b976542b550f36cf.shtml. |
[5] | Clinical and Laboratory Standards Institute. Principles and procedures for blood cultures[S]. M47-A,CLSI, 2007. |
[6] |
GRACE C J, LIEBERMAN J, PIERCE K, et al. Usefulness of blood culture for hospitalized patients who are receiving antibiotic therapy[J]. Clin Infect Dis, 2001, 32(11):1651-1655.
DOI URL |
[7] | RAND K H, BEAL S G, RIVERA K, et al. Hourly effect of pretreatment with Ⅳ antibiotics on blood culture positivity rate in emergency department patients[J]. Open Forum Infect Dis, 2019,6(5):ofz179. |
[8] | 桑福德. 热病[M]. 范洪伟,译. 北京: 中国协和医科大学出版社, 2010. |
[9] |
KIRN T J, MIRRETT S, RELLER L B, et al. Controlled clinical comparison of BacT/alert FA plus and FN plus blood culture media with BacT/alert FA and FN blood culture media[J]. J Clin Microbiol, 2014, 52(3):839-843.
DOI URL |
[10] |
MILLER N, BRASSINNE L, ALLEMEERSCH D. Implementation of the new VIRTUO blood culture system:evaluation and comparison to the 3D system using simulated blood cultures[J]. Acta Clin Belg, 2018, 73(1):16-20.
DOI URL |
[11] | AHMED A, SATTI L, ZAMAN G, et al. Catheter related recurrent blood stream infection caused by linezolid-resistant,methicillin resistant Staphylococcus haemolyticus;an emerging super bug[J]. J Pak Med Assoc, 2019, 69(2):261-263. |
[12] |
TARAI B, JAIN D, DAS P, et al. Paired blood cultures increase the sensitivity for detecting pathogens in both inpatients and outpatients[J]. Eur J Clin Microbiol Infect Dis, 2018, 37(3):435-441.
DOI URL |
[13] | 杭亚平, 汪红, 宁长秀, 等. 血流感染葡萄球菌菌种分布及耐药特性分析[J]. 中国微生态学杂志, 2015, 27(2):199-202. |
[1] | ZHAO Yanan, CAO Qixin, YAN Yan, LI Xiaocong, ZHAO Jianping, XIAO Weili. Research progress of CRISPR/Cas13 system for pathogen detection [J]. Laboratory Medicine, 2023, 38(8): 800-804. |
[2] | MA Kaihui, LÜ Zhi, ZHOU Yanyan, SU Jianrong. Characteristic analysis of Clostridium difficile colonization and infection in inpatients [J]. Laboratory Medicine, 2023, 38(2): 153-156. |
[3] | REN Yanfei, ZHANG Min, YANG Tao, LI Rongkai, LIANG Xin. Analysis of pathogenic epidemiology of patients with lower respiratory tract infection in respiratory intensive care unit [J]. Laboratory Medicine, 2023, 38(2): 157-162. |
[4] | TIAN Yuanyuan, JIA Xiongfei. Advantages and pathogenicity of Enterococci [J]. Laboratory Medicine, 2023, 38(11): 1101-1105. |
[5] | CHEN Hanlu, WU Shenghai. Influence factors of blood culture negative results and progress of pathogen detection in bloodstream infection [J]. Laboratory Medicine, 2022, 37(7): 688-694. |
[6] | WANG Jianying, WANG Shanshan, ZHU Jun, HUANG Xiaochun, WAN Yuxiang, LIU Yun. Distribution and drug resistance of respiratory infection pathogens in patients with lung cancer after chemotherapy [J]. Laboratory Medicine, 2022, 37(4): 356-359. |
[7] | CHU Minjun, LI Xiaojuan, HUANG Hailin, LI Jue, MA Mingbiao, DU Tingyi, WANG Haiping. Influence of delayed entry on fastidious bacterium culture in 2 blood culture systems [J]. Laboratory Medicine, 2022, 37(3): 209-212. |
[8] | PAN Yunqi, LI Yungai, WANG Jianqiang, WU Qiong, TANG Jin. Analysis of molecular typing,virulence genes and antibiotic susceptibility of uropathogenic Escherichia coli in patients with recurrent urinary tract infection [J]. Laboratory Medicine, 2022, 37(2): 141-145. |
[9] | YANG Xi, SONG Wenqi, DONG Fang, MENG Qingying, ZHEN Jinghui, ZHOU Wei. Application of Gram staining and MALDI-TOF MS in the rapid identification of pathogen kinds in children's positive blood culture [J]. Laboratory Medicine, 2022, 37(10): 969-973. |
[10] | LIU Hongqian, SONG Chaohui, LIANG Qiaomi. Establishment and clinical application of multiple RT-PCR MassARRAY for the determinations of 27 respiratory pathogens [J]. Laboratory Medicine, 2021, 36(9): 939-946. |
[11] | HE Ping'an, LU Yanzhou, YANG Xu, LÜ Mei, XIA Qing, LI Qingrong. Research progress in burn infection pathogens and drug resistance with the length of stay during hospitalization [J]. Laboratory Medicine, 2021, 36(9): 973-975. |
[12] | LI Yanchun, TIAN Bin, YUE Na, HU Zhidong. Analysis for distribution and drug resistance of fungemia pathogen from 2014 to 2020 in a Tianjin hospital [J]. Laboratory Medicine, 2021, 36(8): 800-804. |
[13] | WANG Bowen, ZENG Xiaohua, PENG Kaige, LIU Chang, WU Yingchao, HUANG Yingmei, MA Panpan, Lamuciren , LI Guokai, YANG Li. Influence of different inactivating conditions on nucleic acid determination for respiratory pathogens [J]. Laboratory Medicine, 2021, 36(8): 805-808. |
[14] | YU Jiajia, LI Yuanrui, LIU Ying. MALDI-TOF MS combined with SDS and SAP pretreatment for rapid identification of positive blood culture [J]. Laboratory Medicine, 2021, 36(8): 864-868. |
[15] | HOU Weiwei, JIANG Lian, LI Dong. Clinical application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry in the direct detection of blood culture positive specimens [J]. Laboratory Medicine, 2021, 36(4): 424-429. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||